Key Highlights

  • FDA nominee Dr. Heidi Overton told senators that all vaccines currently on the US market are safe and effective, including the MMR shot.
  • Senate HELP Committee Chairman Bill Cassidy pressed Overton on standing behind an executive order that broke up the childhood Vaccine schedule into more doses.
  • Democratic senators focused on Overton's anti-abortion views and her position on the abortion pill mifepristone, which the FDA is reviewing under an October 7 court deadline.
  • If confirmed, Overton would take over an FDA that has lost more than 3,000 staff over the past year.

Overton Affirms Vaccine Safety Under Questioning

Dr. Heidi Overton, President Trump's nominee to lead the FDA, told senators on Thursday that every vaccine currently on the US market is safe and effective, as the Senate health committee's Republican chairman pressed her on Immunization policy during her confirmation hearing. Senator Bill Cassidy of Louisiana, himself a physician, asked Overton to affirm the safety of the measles, mumps and rubella vaccine and to commit to keeping politics out of the agency's decisions.

"Yes, senator, the MMR vaccine is safe and effective," Overton said. "Every vaccine on the US market right now are safe and effective according to the FDA," she added when Cassidy asked whether any were not. Cassidy criticized Overton for standing behind Trump when the president signed an executive order breaking the childhood vaccine schedule into additional doses, a move opposed by physicians' groups and vaccine manufacturers, saying the order was based on "zero scientific evidence" and would raise costs for families. Cassidy also noted Overton's presence when Trump previously described the MMR shot as "potentially quite lethal," pressing her on whether she would break with that characterization amid the country's worst measles outbreak in decades. "The MMR vaccine is not lethal," Overton said.

A White House Insider Nominated to Steady the Agency

Trump nominated Overton, a White House policy aide and deputy director of the Domestic Policy Council, in August, turning to an ally to stabilize an agency that has been shaken by staff departures, low morale and disputes over vaccines, the abortion pill and drug approvals. If confirmed, Overton would inherit an FDA that has lost more than 3,000 staff over the past year, including division heads, and faces pressure to rebuild confidence among both industry and public-health groups. Overton previously worked at a conservative think tank before joining the White House.

Democrats Focus on Abortion Pill Stance

Overton's anti-abortion views drew sustained scrutiny from Democratic senators. She had previously described the Supreme Court's 2022 decision overturning Roe v. Wade as "a huge victory for life." Senator Patty Murray of Washington repeatedly pressed Overton on whether she personally believes the abortion pill mifepristone is safe and effective; Overton declined to answer directly, saying her role would be to abide by the statutory safety and efficacy standards. "I know that it has met the safety and efficacy standard according to the FDA review," she said. Murray also noted that Overton had published an article three years ago describing medication abortion as dangerous, calling it "alarming" that a nominee would contradict established scientific evidence.

If confirmed, Overton would inherit an FDA review of mifepristone that abortion-rights advocates argue is politically motivated, with the agency facing an October 7 deadline to update a federal court on its progress.

Flavored Vapes Also Draw Scrutiny

Republican Senator Susan Collins of Maine pressed Overton on the FDA's August authorization of several new flavored nicotine pouches and vapes, calling it a "terrible decision" that could reverse progress in reducing youth e-cigarette use. Overton did not disavow the approvals, saying career FDA staff had recommended them because many adults who quit smoking use flavored products. Democratic Senator Chris Murphy of Connecticut alleged political interference in the decision, which Overton rejected.

Outlook

Whether Overton is confirmed will likely depend on how senators weigh her vaccine-safety commitments against continued Democratic concerns over her abortion-related positions. The Senate HELP Committee is expected to vote on her nomination in the coming weeks.